Lenvatinib/programmed cell death-1 receptor antagonistsPain: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1906卷 / 1期
关键词：
D O I：
10.1007/s40278-022-15129-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：239 / 239
相关论文
共 50 条
  • [41] Discovery of the programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing an indoline scaffold
    Qin, Mingze
    Cao, Qi
    Wu, Xia
    Liu, Chunyang
    Zheng, Shuaishuai
    Xie, Hongbo
    Tian, Ye
    Xie, Jun
    Zhao, Yanfang
    Hou, Yunlei
    Zhang, Xian
    Xu, Boxuan
    Zhang, Haotian
    Wang, Xiaobo
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 186
  • [42] Expression patterns of programmed death-1 and programmed death-1 ligand-1 on T cells in gastric cancer
    Kim, Ji-Hyun
    Kim, Shinn-Young
    Shin, Eun-Young
    Jung, Ji-Han
    Choi, Hyun-Joo
    Jun, Kyong-Hwa
    ONCOLOGY LETTERS, 2019, 18 (03) : 2661 - 2669
  • [43] Progress in programmed cell death-1/programmed cell death-ligand 1 pathway inhibitors and binding mode analysis
    Li, Xiaoyun
    Zeng, Qin
    Xu, Fengjiao
    Jiang, Yuying
    Jiang, Zhongmei
    MOLECULAR DIVERSITY, 2023, 27 (04) : 1935 - 1955
  • [44] Ipilimumab/programmed-cell-death-1-receptor-antagonistsImmune-related pneumonitis: case report
    Reactions Weekly, 2020, 1789 (1) : 152 - 152
  • [45] Progress in programmed cell death-1/programmed cell death-ligand 1 pathway inhibitors and binding mode analysis
    Xiaoyun Li
    Qin Zeng
    Fengjiao Xu
    Yuying Jiang
    Zhongmei Jiang
    Molecular Diversity, 2023, 27 : 1935 - 1955
  • [46] SAR study of small molecule inhibitors of the programmed cell death-1/programmed cell death-ligand 1 interaction
    Kawashita, Seiji
    Aoyagi, Koichi
    Fukushima, Kyoko
    Hantani, Rie
    Naruoka, Shiori
    Tanimoto, Atsuo
    Hori, Yuji
    Toyonaga, Yukiyo
    Yamanaka, Hiroshi
    Miyazaki, Susumu
    Hantani, Yoshiji
    CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 98 (05) : 914 - 929
  • [47] Metastatic Clear Cell Renal Cell Carcinoma with Hyperprogressive Disease after Anti-Programmed Death-1 Immunotherapy: A Case Report
    Wong, K. K. S.
    Sze, H. C. K.
    HONG KONG JOURNAL OF RADIOLOGY, 2020, 23 (02): : 130 - 133
  • [48] Simultaneous development of Graves' disease and type 1 diabetes during anti-programmed cell death-1 therapy: A case report
    Kurihara, Susumu
    Oikawa, Yoichi
    Nakajima, Ritsuko
    Satomura, Atsushi
    Tanaka, Ryuhei
    Kagamu, Hiroshi
    Shimada, Akira
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (04) : 1006 - 1009
  • [49] Targeting the programmed death-1/programmed death-ligand 1 axis in lymphoma
    Cheah, Chan Yoon
    Fowler, Nathan H.
    Neelapu, Sattva S.
    CURRENT OPINION IN ONCOLOGY, 2015, 27 (05) : 384 - 391
  • [50] Diffuse hair loss following anti-programmed cell death-1 antibody treatment: a case report with immunohistochemical analysis
    Takayoshi Komatsu-Fujii
    Atsushi Otsuka
    Yoshihiro Ishida
    Yo Kaku
    Chisato Yamashita
    Akitaka Hata
    Tatsuki Kataoka
    Tetsuya Honda
    Kenji Kabashima
    European Journal of Dermatology, 2019, 29 : 326 - 327
12345